Disclosures for "A Standardized Patient-based Simulation Study on Herpes Simplex Virus (HSV) Encephalitis in a Preclinical Neuroscience Curriculum"
-
Dr. Schleinkofer has nothing to disclose.
-
Dr. Kaleem has nothing to disclose.
-
Dr. Naik has nothing to disclose.
-
Dr. Goman has nothing to disclose.
-
Mrs. Harvey has nothing to disclose.
-
Ms. Connolly has nothing to disclose.
-
Dr. Abramson has nothing to disclose.
-
Dr. Safdieh has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Safdieh has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Dughi, Hewit & Domalewski, P.C.. Dr. Safdieh has received publishing royalties from a publication relating to health care.
-
Dr. Katz has nothing to disclose.
-
Dr. Noch has received personal compensation for serving as an employee of Destroke, Inc.. Dr. Noch has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lexeo Therapeutics. Dr. Noch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Advarra, Inc.. Dr. Noch has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Imedview, Inc.. Dr. Noch has stock in Destroke, Inc..